bictegravirraltegravir/elvitegravir-baseddolutegravir-basedprotease inhibitor-basedPWHItalian NGS Network
…-RNA was 3.9 (IQR: 3.0–4.8) log10 copies/mL. PWH were receiving bictegravir/dolutegravir-based (37.0%), raltegravir/elvitegravir-based (22.…
Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
This drug is selected. Its supporting articles are shown below.
…-RNA was 3.9 (IQR: 3.0–4.8) log10 copies/mL. PWH were receiving bictegravir/dolutegravir-based (37.0%), raltegravir/elvitegravir-based (22.…
… and clinicians in proactive surveillance of patients receiving dolutegravir. Prospective validation and workflow integration will be requir…